Project details
- Project period
- 1 Aug 2024 - 31 Jul 2026
- Total cost
- €1 260 000,00
- Global Health EDCTP3 funding
- €1 260 000,00
- Call identifier
- HORIZON_HORIZON-JU-GH-EDCTP3-2024-Mpox
- Status
- In progress
- Project type
- Research and Innovation Actions (RIA)
- Disease area
- Emerging or re-emerging infectious diseases
- Intervention type
- Surveillance tools
Consortium map
Coordinator
NATIONAL HEALTH LABORATORY SERVICES
- Location
- Sandringham, South Africa
- EU contribution
- €156 750,00
- Total cost
- €156 750,00
Beneficiaries
MCMASTER UNIVERSITY
- Location
- Hamilton, Canada
INSTITUT NATIONAL DE RECHERCHE BIOMEDICALE DU ZAIRE
- Location
- KINSHASA GOMBE, Democratic Republic of the Congo
- EU contribution
- €146 000,00
- Total cost
- €146 000,00
MAKERERE UNIVERSITY
- Location
- Kampala, Uganda
- EU contribution
- €156 750,00
- Total cost
- €156 750,00
THE UNIVERSITY OF LIVERPOOL
- Location
- LIVERPOOL, United Kingdom
- EU contribution
- €399 750,00
- Total cost
- €399 750,00
UGANDA NATIONAL HEALTH RESEARCH ORGANISATION
- Location
- Entebbe, Uganda
- EU contribution
- €176 000,00
- Total cost
- €176 000,00
UNIVERSITE CATHOLIQUE DE BUKAVU
- Location
- BUKAVU, Democratic Republic of the Congo
- EU contribution
- €224 750,00
- Total cost
- €224 750,00
Related projects
Supporting mpox responses and research in eastern DRCThe MBOTE-SK project is embedding research within the response to the new clade Ib mpox outbreak in eastern DRC.
Rapid protection against Ebola virusThe EBO-PEP project is evaluating whether monoclonal antibodies can protect close contacts of people with Ebola virus infections.
Pregnant women have an increased risk of severe mpox disease, however, the underlying mechanisms remain elusive. To better understand altered transmission pattern of MPXV and its impact on...